|
A recent US study has linked the diabetes type 2 drug rosiglitazone (brand name Avandia) to increased risk of heart attack and cardiovascular death and
has led to the Food and Drug Administration (FDA) issuing a safety alert to doctors to be aware of |
|
Patients with liver disease often suffer from other related illnesses, including type-2 diabetes, obesity and high blood pressure, among others. Research presented at Digestive Disease Week 2007 (DDW) explores the many unknowns of liver disease by examin |
|
Research presented at Digestive Disease Week 2007 (DDW) introduces unique methods for evaluating patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the most common liver disease in the world and the development of novel procedures for defi |
|
An oversupply of fatty acids plays a key role in the development of insulin resistance in the skeletal muscle of obese individuals. Two related studies appearing online in advance of publication in the June print issue of the Journal of Clinical Investig |
|
Juvenile Diabetes Research Foundation, the world's largest charitable funder of type 1 diabetes research, today announced the recipients of its second annual Scholar Awards. The award provides sustained support for individual scientists of extraordinary |
|
Trophos SA, a biopharmaceutical company specializing in the discovery and development of drugs for neurological disorders, announced today that the first patients have been enrolled in a Phase IIa clinical trial of its of lead product, TRO19622. The rand |
|
A glucosamine-like dietary supplement has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus, according to University of California, Irvine health sciences researchers.
|
